India to get 100 million AstraZeneca's Covid vaccines next month: Serum Institute head

If final-stage trial data show AstraZeneca’s candidate gives effective protection from the virus, the Serum Institute of India Ltd. -- which is partnered to produce at least one billion doses -- may get emergency authorization from New Delhi by December, said Adar Poonawalla.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/32INBb4
via IFTTT